These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 33178011)

  • 1. Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients.
    Yang F; Yue R; Luo X; Liu R; Huang X
    Front Pharmacol; 2020; 11():543718. PubMed ID: 33178011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
    Chatterjee SK; Saha S; Munoz MNM
    Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
    Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
    Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients.
    Bosch-Barrera J; Martin-Castillo B; Buxó M; Brunet J; Encinar JA; Menendez JA
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32517353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia.
    Keiffer G; French Z; Wilde L; Filicko-O'Hara J; Gergis U; Binder AF
    Front Oncol; 2020; 10():562625. PubMed ID: 33072589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylprednisolone pulse therapy: An alternative management of severe COVID-19.
    Sauñe PM; Bryce-Alberti M; Portmann-Baracco AS; Accinelli RA
    Respir Med Case Rep; 2020; 31():101221. PubMed ID: 32995261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis.
    Kassem DH; Kamal MM
    Front Cell Dev Biol; 2020; 8():587866. PubMed ID: 33102489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome and COVID-19.
    Otsuka R; Seino KI
    Inflamm Regen; 2020; 40():19. PubMed ID: 32834892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections.
    Chrzanowski W; Kim SY; McClements L
    Front Bioeng Biotechnol; 2020; 8():554. PubMed ID: 32574317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence.
    Barré J; Sabatier JM; Annweiler C
    Front Pharmacol; 2020; 11():1344. PubMed ID: 33013375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
    Shibabaw T
    J Inflamm Res; 2020; 13():673-680. PubMed ID: 33116747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Covid-19?
    Bonaz B; Sinniger V; Pellissier S
    Bioelectron Med; 2020; 6():15. PubMed ID: 32743022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review.
    Napoli C; Tritto I; Benincasa G; Mansueto G; Ambrosio G
    Ann Med Surg (Lond); 2020 Sep; 57():236-243. PubMed ID: 32802325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
    Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
    Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular hydrogen as an adjuvant therapy may be associated with increased oxygen saturation and improved exercise tolerance in a COVID-19 patient.
    Singh RB; Halabi G; Fatima G; Rai RH; Tarnava AT; LeBaron TW
    Clin Case Rep; 2021 Nov; 9(11):e05039. PubMed ID: 34765212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment With Tocilizumab for Patients With COVID-19 Infections: A Case-Series Study.
    Mo Y; Adarkwah O; Zeibeq J; Pinelis E; Orsini J; Gasperino J
    J Clin Pharmacol; 2021 Mar; 61(3):406-411. PubMed ID: 33180360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights from nanotechnology in COVID-19 treatment.
    Tang Z; Zhang X; Shu Y; Guo M; Zhang H; Tao W
    Nano Today; 2021 Feb; 36():101019. PubMed ID: 33178330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia.
    Khamis F; Al Naabi H; Al Lawati A; Ambusaidi Z; Al Sharji M; Al Barwani U; Pandak N; Al Balushi Z; Al Bahrani M; Al Salmi I; Al-Zakwani I
    Int J Infect Dis; 2021 Jan; 102():538-543. PubMed ID: 33181328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection.
    Monteil V; Dyczynski M; Lauschke VM; Kwon H; Wirnsberger G; Youhanna S; Zhang H; Slutsky AS; Hurtado Del Pozo C; Horn M; Montserrat N; Penninger JM; Mirazimi A
    EMBO Mol Med; 2021 Jan; 13(1):e13426. PubMed ID: 33179852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence.
    Kotak S; Khatri M; Malik M; Malik M; Hassan W; Amjad A; Malik F; Hassan H; Ahmed J; Zafar M
    Cureus; 2020 Oct; 12(10):e10869. PubMed ID: 33178522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.